Wall Street analyst estimates for Nuwellis, Inc. (NUWE): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 0.50 |
Valuation Ratios
| Price / Book | -0.07 |
| EV / EBITDA | 0.50 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $3.6M | $5.0M | $5.5M | $7.4M | $7.9M | $8.5M | $8.9M | $8.7M | $8.3M |
| Cost of Revenue | $713000 | $2.8M | $3.7M | $2.7M | $3.4M | $3.4M | $3.8M | $3.9M | $2.9M | $3.1M |
| Gross Profit | $576000 | $790000 | $1.3M | $2.9M | $4.1M | $4.5M | $4.8M | $5.0M | $5.8M | $5.1M |
| Research & Development | $8.1M | $1.5M | $3.1M | $4.7M | $3.7M | $5.0M | $4.3M | $5.4M | $3.2M | $2.7M |
| Selling, General & Admin | $8.1M | $10.2M | $15.3M | $16.3M | $17.4M | $19.0M | $17.6M | $17.2M | 0 | $13.5M |
| Operating Expenses | $16.2M | $11.7M | $18.4M | $21.0M | $21.1M | $24.0M | $21.9M | $22.6M | $16.8M | $16.2M |
| Operating Income | -$15.7M | -$14.8M | -$17.0M | -$18.1M | -$17.0M | -$19.5M | -$17.2M | -$17.6M | -$11.0M | -$11.1M |
| EBITDA | -$14.6M | -$10.1M | -$16.8M | -$17.9M | -$16.7M | -$19.1M | -$4.9M | -$16.4M | -$10.5M | -$6.5M |
| Interest Expense | $504000 | $2.5M | 0 | 0 | 0 | 0 | $9.2M | $3.5M | $5.6M | $10.6M |
| Pre-tax Income | -$15.8M | -$13.4M | -$17.0M | -$18.1M | -$15.8M | -$19.5M | -$14.5M | -$20.2M | -$11.2M | -$17.5M |
| Income Tax | -$54000 | $6000 | $6000 | $8000 | $9000 | $9000 | $9000 | $8000 | $5000 | $5000 |
| Net Income | -$15.8M | -$13.4M | -$17.0M | -$18.1M | -$15.8M | -$19.6M | -$14.5M | -$20.2M | -$11.2M | -$17.5M |
| EPS | $-184240000.00 | $-156123333.45 | $-149030000.00 | $-14408863.70 | $-709679.95 | $-350143.15 | $-102268.25 | $-12602.45 | $-280.00 | $-25.39 |
| EPS (Diluted) | $-184240000.00 | $-156123333.45 | $-149030000.00 | $-14408863.70 | $-709679.95 | $-350143.15 | $-102268.25 | $-12602.45 | $-280.00 | $-25.39 |
| Shares Outstanding (Diluted) | $0 | $0 | $0 | $1 | $22 | $56 | $142 | $1604 | $37921 | $197184 |
Price
| Price | $0.81 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ACON · BACK · BCTXW · IVF · NUVO · OCEA · PETV
Explore sector: Healthcare · Medical - Devices
More sections of NUWE: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks